Delivery Order SPE2DB24D2205-SPE2DB25FEBUH
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.35, is for the delivery of Amoxicillin-Clavulanic Acid 250-125 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program and is open to full and open competition....
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FP5S1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,440.68 firm fixed-price delivery order is for the supply of 100 tablets of the drug Amoxicillin-Clavulanate 875-125 mg. This order falls under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
This federal contract award is for $1,891.59 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMOX-CLAV 875-125 MG TABLET 100S, a type of antibiotic medication, and has an ultimate completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Amoxicillin-Clavulanate 875-125 mg tablets, a common antibiotic medication, to support military healthcare programs. The contract has a ceiling value of $1,668.36 and an ultimate completion date of January 28, 2025. It is a firm-fixed price contract and does not have a set-aside...
This federal contract award, valued at $11,271.08, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Amoxicillin-Clavulanate 1,000-62.5 mg tablets, a pharmaceutical product used to treat bacterial infections. The contract has an ultimate completion date of September 19, 2023 and is structured as a firm fixed-price delivery order. The contract was awarded on an unrestricted basis, with no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Amoxicillin-Clavulanic Acid 1,000-62.5 mg tablets. The contract has a firm fixed price of $1,437.48 and a completion date of March 12, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,032.05 contract is for the delivery of 20-count blister packs of Amox-Clav 875-125 mg tablets. This delivery order falls under an existing $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as a single-award vehicle. The IDC serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,378.66, is for the delivery of Amoxicillin-Clavulanate 1,000-62.5 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 27, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,668.84 delivery order contract is for the procurement of AMOX-CLAV 875-125 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 12, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,751.50, is for the delivery of Amoxicillin/Clavulana, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a performance period ending on May 7, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, was awarded this contract without...